Reduced availability of brain amines during critical phases of postnatal development in a genetic mouse model of cognitive delay

Brain Research

Volumn 1217, Issue , 2008, Pages 232-238

  Pascucci, Tiziana ^a,b   Andolina, Diego ^a,b   Ventura, Rossella ^b,c   Puglisi Allegra, Stefano ^a,b   Cabib, Simona ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

5 HTP; Blood brain barrier; Critical period; Hydroxylase activity; Hyperphenylalaninemia; l DOPA; Neurodevelopmental disorders; Tryptophan; Tyrosine

Indexed keywords

5 HYDROXYTRYPTOPHAN; BRAIN AMINE; DOPA; DOPAMINE; NORADRENALIN; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EXPERIMENTAL MODEL; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PAHENU2 MICE; PHENYLKETONURIA; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

AMINES; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; MICE; MICE, MUTANT STRAINS; PHENYLKETONURIAS;

MUS;

EID: 45449105540     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.04.006     Document Type: Article

References (41)

1. Bauman M.L., and Kemper T.L. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol. 58 (1982) 55-63
2. Beique J.C., Chapin-Penick E.M., Mladenovic L., and Andrade R. Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex. J. Physiol. 556 (2004) 4807-4817
3. Bennett-Clarke C.A., Lane R.D., and Rhoades R.W. Fenfluramine depletes serotonin from the developing cortex and alters thalamocortical organization. Brain Res. 702 (1995) 225-260
4. Bennett-Clarke C.A., Leslie M.J., Lane R.D., and Rhoades R.W. Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex. J. Neurosci. 14 (1994) 7594-7607
5. Bonafé L., Blau N., Burlina A.P., Romstad A., Guttler F., and Burlina A.B. Treatable neurotransmitter deficiency in mild phenylketonuria. Neurology 57 (2001) 908-911
6. Brust P., Vorwieger G., Walter B., Fuchtner F., Stark H., Kuwabara H., Herzau M., Opfermann T., Steinbach J., Ganapathy V., and Bauer R. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study. Brain Res. Dev. 152 (2004) 241-253
7. Burlina A.B., Bonafe L., Ferrari V., Suppiej A., Zacchello F., and Burlina A.P. Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment. J. Inherit. Metab. Dis. 23 (2000) 313-316
8. Cabib S., Pascucci T., Ventura R., Romano V., and Puglisi-Allegra S. The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria. Behav. Genet. 33 (2003) 301-310
9. Cases O., Vitalis T., Seif I., De Maeyer E., Sotelo C., and Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16 (1996) 297-307
10. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45 (1999) 287-295
11. Curtius H.C., Niederwieser A., Viscontini M., Leimbacher W., Wegmann H., Blehova B., Rey F., Schaub J., and Schmidt H. Serotonin and dopamine synthesis in phenylketonuria. Adv. Exp. Med. Biol. 133 (1981) 277-291
12. Embury J.E., Charron C.E., Martynyuk A., Zori A.G., Liu B., Ali S.F., Rowland N.E., and Laipis P.J. PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice. Brain Res. 1127 (2007) 136-150
13. Fernstrom J.D., and Fernstrom M.H. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J. Nutr. 137 (2007) 1539S-1547S
14. Goldman-Rakic P.S., and Brown R.M. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Brain Res. 256 (1982) 339-349
15. Herlenius E., and Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum. Dev. 65 (2001) 21-37
16. Huttenlocher P.R. Dendritic and synaptic pathology and mental defect. Pediatr. Neurol. 7 (1991) 79-85
17. Huttenlocher P.R. The neuropathology of phenylketonuria: human and animal studies. Eur. J. Pediatr. 159 (2000) 102-106
18. Joseph B., and Dyer C.A. Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J. Neurochem. 86 (2003) 615-626
19. Kornguth S., Gilbert-Barness E., Langer E., and Hegstrand L. Golgi-Kopsch silver study of the brain of a patient with untreated phenylketonuria, seizures and cortical blindness. Am. J. Med. Gen. 44 (1992) 443-448
20. Knudsen G.M., Hasselbalch S., Toft P.B., Christensen E., Paulson O.B., and Lou H. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J. Inherit. Metab. Dis. 18 (1995) 653-664
21. Lou H.C., Guttler F., Lykkelund C., Bruhn P., and Niederwieser A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur. J. Pediatr. 144 (1985) 17-20
22. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A., and Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760 (1997) 68-73
23. McDonald J.D., Bode V.C., Dove W.F., and Shedlovsky A. Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1965-1967
24. McKean C.M. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res. 47 (1972) 469-476
25. Okado N., Narita M., and Narita N. A biogenic amine-synapse mechanism for mental retardation and developmental disabilities. Brain Dev. 23 (2001) S11-S15
26. Ogawa S., and Ichinose H. Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: comparison with that on tyrosine hydroxylase activity. Neurosci. Lett. 401 (2006) 261-265
27. Pascucci T., Ventura R., Puglisi-Allegra S., and Cabib S. Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria. Neuroreport 13 (2002) 2561-2564
28. Persico A.M., Mengual E., Moessner R., Hall F.S., Revay R.S., Sora I., Arellano J., DeFelipe J., Gimenez-Amaya J.M., Conciatori M., Marino R., Baldi A., Cabib S., Pascucci T., Uhl G.R., Murphy D.L., Lesch K.P., and Keller F. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 21 (2001) 6862-6873
29. Pietz J. Neurological aspects of adult phenylketonuria. Curr. Opin. Neurol. 11 (1998) 679-688
30. Pietz J., Kries R., Rupp A., Mayatepek E., Rating D., Boesch C., et al. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J. Clin. Invest. 103 (1999) 1169-1178
31. Puglisi-Allegra S., Cabib S., Pascucci T., Ventura R., Calì F., and Romano V. Dramatic brain aminergic deficits in a genetic mouse model of phenylketonuria. Neuroreport 11 (2000) 1361-1364
32. Ribatti D., Nico B., Crivellato E., and Artico M. Development of the blood-brain barrier: a historical point of view. Anat. Rec. B. New Anat. 289 (2006) 3-8
33. Scriver C.R., and Kaufman S. The hyperphenylalanenemias: phenylalanine hydroxylase deficiency. In: Scriver C.R., William S.S., Childs B., Beaudet A.L., Valle D., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 1667-1724
34. Shedlovsky A., McDonald J.D., Symula D., and Dove W.F. Mouse model of phenylketonuria. Genetics 134 (1993) 1205-1210
35. Sodhi M.S., and Sanders-Bush E. Serotonin and brain development. Int. Rev. Neurobiol. 59 (2004) 111-174
36. Surtees R., and Blau N. The neurochemistry of phenylketonuria. Eur. J. Pediatr. 2 (2000) 109-113
37. Van Eden C.G., and Uylings H.B. Cytoarchitectonic development of the prefrontal cortex in the rat. J. Comp. Neurol. 241 (1985) 253-267
38. Vitalis T., and Parnavelas J.G. The role of serotonin in early cortical development. Dev. Neurosci. 25 (2003) 245-256
39. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 56 (2001) 479-485
40. Williams R.S., Hauser S.L., Purpura D.P., DeLong G.R., and Swisher C.N. Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch. Neurol. 37 (1980) 749-753
41. Wiesel F.A., Edman G., Flyckt L., Eriksson A., Nyman H., Venizelos N., and Bjerkenstedt L. Kinetics of tyrosine transport and cognitive functioning in schizophrenia. Schizophr. Res. 74 (2005) 81-89